Latest News and Press Releases
Want to stay updated on the latest news?
-
PARIS et CAMBRIDGE, Mass., 21 mai 2026 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO – NASDAQ: NBTX – « Nanobiotix » ou la « Société »), une société de biotechnologie au stade clinique et en phase...
-
TORONTO, May 21, 2026 (GLOBE NEWSWIRE) -- OpenTable, a global leader in restaurant technology, announced today that it has signed a multi-year lease agreement for its new Toronto office at Allied’s...
-
CORRECTION -- Data I/O to Present at the Planet MicroCap Investor Conference Powered by MicroCapClub
REDMOND, Wash., May 21, 2026 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by Data I/O Corporation, please note that in the 2026 business framework section in the...
-
BOSTON, May 21, 2026 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana”), a biotechnology company developing its lead candidate, intranasal foralumab, a fully human, anti-CD3...
-
PARIS, France and CAMBRIDGE, Mass., May 21, 2026 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO – NASDAQ: NBTX – “Nanobiotix” or the “Company”), a late-clinical stage biotechnology company...
-
PARIS, France and CAMBRIDGE, Mass., May 21, 2026 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO – NASDAQ: NBTX – “Nanobiotix” or the “Company”), a late-clinical stage biotechnology company...
-
BROOKINGS, S.D., May 21, 2026 (GLOBE NEWSWIRE) -- Daktronics Inc. (Nasdaq: DAKT), the leading U.S.-based designer and manufacturer of best-in-class dynamic video communication displays and control...
-
MIRAMAR, Fla., May 21, 2026 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company” or “HCW Biologics”), (NASDAQ: HCWB), a clinical-stage biopharmaceutical company developing transformative fusion...
-
SINGAPORE, May 21, 2026 (GLOBE NEWSWIRE) -- Trident Digital Tech Holdings Ltd. (Nasdaq: TDTH) (“Trident” or the “Company”), a Singapore-headquartered digital infrastructure holding company focused...
-
PARIS and CAMBRIDGE, Mass., May 21, 2026 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO – NASDAQ: NBTX – “Nanobiotix” or the “Company”), a late-clinical stage biotechnology company pioneering...